HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Nasehi Selected Research

Mohammad Nasehi Research Topics

Disease

32Amnesia (Dissociative Amnesia)
06/2021 - 10/2009
19Memory Disorders (Memory Loss)
06/2021 - 01/2013
15Sleep Deprivation
02/2022 - 01/2016
12Cholestasis
10/2021 - 11/2011
4Cognitive Dysfunction
04/2022 - 11/2013
4Hepatic Encephalopathy
12/2020 - 02/2013
4Pain (Aches)
01/2020 - 09/2017
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2021 - 01/2020
3Alzheimer Disease (Alzheimer's Disease)
03/2021 - 04/2014
2Stroke (Strokes)
04/2022 - 01/2020
2Multiple Sclerosis
04/2022 - 02/2020
2Mental Disorders (Mental Disorder)
01/2022 - 01/2020
2Inflammation (Inflammations)
12/2020 - 01/2017
1Necrosis
06/2022
1Autism Spectrum Disorder
06/2022
1Schizophrenia (Dementia Praecox)
04/2022
1Neuroinflammatory Diseases
10/2021
1Ischemic Stroke
07/2021
1Sleep Wake Disorders
10/2020
1Substance-Related Disorders (Drug Abuse)
06/2020
1Hyperalgesia
01/2019
1Autistic Disorder (Autism)
05/2018
1Neurodevelopmental Disorders
05/2018

Drug/Important Bio-Agent (IBA)

8harman (harmane)IBA
09/2019 - 05/2010
7SCH 23390IBA
01/2021 - 02/2013
7Sulpiride (neogama)IBA
01/2021 - 02/2013
7Anti-Anxiety Agents (Anxiolytics)IBA
10/2017 - 11/2011
7Naloxone (Narcan)FDA LinkGeneric
10/2016 - 11/2011
6CannabinoidsIBA
01/2021 - 01/2015
6CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2016 - 10/2009
5NeuroaidIBA
08/2021 - 01/2019
5RS 67333IBA
06/2021 - 03/2014
5Scopolamine (Hyoscine)FDA Link
01/2021 - 03/2012
5Morphine (MS Contin)FDA LinkGeneric
06/2020 - 03/2012
5Opioid Analgesics (Opioids)IBA
01/2019 - 11/2011
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2017 - 10/2011
4Dopamine AntagonistsIBA
01/2021 - 08/2013
45-HT4 Serotonin ReceptorsIBA
01/2020 - 03/2014
4Pharmaceutical PreparationsIBA
01/2018 - 10/2009
4Dopamine (Intropin)FDA LinkGeneric
08/2013 - 05/2010
3Therapeutic UsesIBA
04/2022 - 02/2020
3AntioxidantsIBA
10/2021 - 06/2020
3salicylhydroxamic acid (SHAM)IBA
03/2021 - 06/2013
3AM 251 (AM251)IBA
01/2021 - 10/2009
3MuscimolIBA
01/2018 - 01/2015
3Cholinergic Agents (Cholinergics)IBA
10/2017 - 03/2012
3azasetronIBA
09/2017 - 03/2014
3Dizocilpine Maleate (Dizocilpine)IBA
04/2016 - 10/2011
3mu Opioid Receptors (mu Opioid Receptor)IBA
04/2014 - 06/2013
3N-Methylaspartate (NMDA)IBA
11/2013 - 10/2011
3NG-Nitroarginine Methyl Ester (L-NAME)IBA
06/2013 - 03/2012
2Thimerosal (Thiomersal)IBA
06/2022 - 05/2018
2crocinIBA
10/2021 - 06/2021
2Proteins (Proteins, Gene)FDA Link
08/2021 - 01/2020
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2021 - 01/2019
2Yohimbine (Yocon)IBA
01/2020 - 01/2016
2Clonidine (ST 155)FDA LinkGeneric
01/2020 - 01/2016
2Dopamine Agents (Dopaminergic Agents)IBA
09/2019 - 10/2012
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2017 - 04/2014
2AlkaloidsIBA
12/2016 - 05/2010
2Adrenergic Receptors (Adrenergic Receptor)IBA
01/2016 - 01/2016
2arachidonylcyclopropylamideIBA
11/2015 - 04/2015
2HarmalineIBA
07/2015 - 10/2014
2Arginine (L-Arginine)FDA Link
06/2013 - 01/2013
1Immunologic Factors (Immunomodulators)IBA
02/2022
1EpitopesIBA
02/2022
1LithiumIBA
01/2022
1CatalaseIBA
10/2021
1Superoxide DismutaseIBA
10/2021
1punicalaginIBA
03/2021
1Inflammation MediatorsIBA
03/2021
1Lithium ChlorideIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
12/2020
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2020
1mitochondrial transcription factor AIBA
12/2020
1propionic acid (potassium propionate)IBA
12/2020
1CurcuminIBA
12/2020
1alpha-2 Adrenergic ReceptorsIBA
12/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2020
1Cocaine (Cocaine HCl)IBA
06/2020
1Neuroprotective AgentsIBA
06/2020
1NeuropeptidesIBA
06/2020
1Amphetamine (Amfetamine)FDA LinkGeneric
06/2020
1Free RadicalsIBA
01/2020
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2020
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
12,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
09/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1Opiate AlkaloidsIBA
01/2019
1Dopamine D2 Receptor AntagonistsIBA
01/2019
1Dopamine Receptors (Dopamine Receptor)IBA
01/2019

Therapy/Procedure

12Ligation
10/2021 - 11/2011
5Injections
09/2019 - 10/2009
4Transcranial Direct Current Stimulation
01/2021 - 11/2017
4Analgesia
01/2019 - 09/2017
3Cognitive Training
04/2022 - 01/2020
1Activities of Daily Living (ADL)
01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019